Promega is a global leader in providing innovative solutions and technical support to life scientists, focused on enabling advancements in research, drug development, and diagnostics.
The CellTiter-Glo® 2.0 Assay is a state-of-the-art luminescence-based solution for measuring cell viability, perfectly designed to complement the MyGlo Reagent Reader. This advanced assay utilizes ATP quantification as an indicator of metabolically active cells, ensuring highly sensitive and reproducible results in biological and drug discovery research.
When paired with the MyGlo Reagent Reader, the CellTiter-Glo® 2.0 Assay delivers unparalleled ease of use and precision. The seamless compatibility between the assay and reader ensures optimal performance, making it the perfect solution for high-throughput screening and various research applications.
Key Applications:
- Cell viability testing in drug discovery.
- Cytotoxicity studies in cancer research.
- High-throughput screening for pharmaceutical applications.
- Features and Benefits:
Perfect Compatibility: Fully optimized for use with the MyGlo Reagent Reader.
High Sensitivity: Detects even subtle changes in cell viability.
Simplified Workflow: Easy-to-follow protocol with minimal handling steps.
Stable Luminescent Signal: Reliable results for extended read time.
Elevate your research with the CellTiter-Glo® 2.0 Assay and MyGlo Reagent Reader, the perfect pairing for accurate and efficient luminescence-based cell viability testing.
Ready to optimize your lab? Order now and save 50% on the CellTiter-Glo® 2.0 Assay with your MyGlo Reagent Reader purchase!